US Patent Issued to Lumiere Therapeutics on Oct. 21 for "CRISPR-Cas systems and uses thereof" (Chinese Inventors)

ALEXANDRIA, Va., Oct. 28 -- United States Patent no. 12,448,630, issued on Oct. 21, was assigned to Lumiere Therapeutics Co. Ltd. (Jiangsu, China).

"CRISPR-Cas systems and uses thereof" was invented by Bohong Chen (Guangzhou, China), Yang Hu (Guangzhou, China), Yulin Yu (Guangzhou, China), Wenqiong Tan (Guangzhou, China), Shaoyun Lin (Guangzhou, China), Wenchang Xu (Guangzhou, China), Youyu Wu (Guangzhou, China), Xiaojie Ma (Guangzhou, China), Jiajun Yu (Guangzhou, China) and Jinshuai Sun (Guangzhou, China).

According to the abstract* released by the U.S. Patent & Trademark Office: "Disclosed herein are a Cas12i polypeptide and use thereof in a CRISPR-Cas system. Specifically disclosed herein are a Cas12i polypeptide, a Cas12i fusion poly...